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ABSTRACT The effects of various surfactants on the activity and stability of the human adenosine A3 receptor (A3) were
investigated. The receptor was expressed using stably transfected HEK293 cells at a concentration of 44 pmol functional
receptor per milligram membrane protein and puriﬁed using over 50 different nonionic surfactants. A strong correlation was
observed between a surfactant’s ability to remove A3 from the membrane and the ability of the surfactant to remove A3
selectively relative to other membrane proteins. The activity of A3 once puriﬁed also correlates well with the selectivity of the
surfactant used. The effects of varying the surfactant were much stronger than those achieved by including A3 ligands in the
puriﬁcation scheme. Notably, all surfactants that gave high efﬁciency, selectivity and activity fall within a narrow range of
hydrophile-lipophile balance values. This effect may reﬂect the ability of the surfactant to pack effectively at the hydrophobic
transmembrane interface. These ﬁndings emphasize the importance of identifying appropriate surfactants for a particular
membrane protein, and offer promise for the development of rapid, efﬁcient, and systematic methods to facilitate membrane
protein puriﬁcation.
INTRODUCTION
G-protein coupled receptors (GPCRs) are thought to be tar-
gets for more than half the currently approved therapeutics
worldwide, yet they and integral membrane proteins as a
whole are grossly underrepresented in terms of available
structural information (1). The number of known GPCRs is
expected to increase as the methods to categorize receptors
improve; of the nearly 2000 GPCRs identiﬁed to date, an
increasing number are so-called ‘‘orphan’’ receptors of which
the function and agonists remain unknown (2). This gap in
knowledge impacts drug discovery efforts, and limits our
understanding of the signal transduction mechanisms un-
derlying many biological processes. Currently high-resolu-
tion structural information is available for only one GPCR,
bovine rhodopsin, thanks in part to its natural abundance (3).
Detailed and efﬁcient puriﬁcation procedures for bovine
rhodopsin have been established that allow recovery of a
large fraction of the expressed protein as well (4). Un-
fortunately, such methods have not translated successfully
to other GPCRs. Therefore, expression and puriﬁcation
remain largely trial-and-error processes (5–7). These ob-
stacles limit the overall ability to characterize GPCR struc-
ture and biochemical properties, especially because their
relative abundance when overexpressed in mammalian sys-
tems is typically ,1 mg/L (8).
Another major limitation in characterizing GPCRs is
knowledge of solution conditions that promote activity and
solubility, because NMR, protein crystallography, or other
biophysical methods require highly puriﬁed samples for
analysis. Despite numerous studies, no general pattern has
emerged as to which surfactant properties are critical for efﬁ-
cient removal of active GPCRs from the membrane (9–12).
More speciﬁcally, nonionic surfactants at concentrations
near the critical micelle concentration have been found to
work best in solubilization of membrane proteins, although
notable exceptions such as the anionic CHAPS, sodium
cholate, and sarkosyl exist (13). Therefore, screening a wide
range of surfactants and carrying out numerous functional
assays are the usual methods to assess and optimize puri-
ﬁcation. Obtaining sufﬁcient receptor is often a limiting
factor, which makes such surfactant screens inefﬁcient and
costly.
We sought to address these difﬁculties by characterizing
the effects of a wide range of surfactants on the puriﬁcation
and activity of the human adenosine A3 receptor (A3) ex-
pressed in a stable mammalian cell line. Speciﬁcally, through
relating surfactant properties to activity and solubility of A3,
we hope to understand the factors most important in iden-
tifying solution conditions favorable for puriﬁcation and crys-
tallization.
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A3 belongs to the superfamily of GPCRs, and is the most
recently identiﬁed of the four known adenosine receptors
(14). The pharmacological proﬁle of A3 most closely re-
sembles that of the adenosine A1 receptor (A1), and both are
thought to mediate cardioprotection, although tissue distri-
butions have identiﬁed isoforms in the brain, lungs, liver,
and testes as well (14). Studies of cardiac myocyte models
suggest that A3 couples to phospholipase D whereas A1
couples to phospholipase C, both of which in turn stimulate
diacylglycerol accumulation and phosphokinase C response
to mediate the protective effects of adenosine (15). In-
terestingly, the duration of A3 response upon activation is
much longer than that of A1, suggesting that they may work
synergistically to greater effect. Thus, we anticipate that our
analysis of A3 will be useful for further characterization of
this important receptor, and will help facilitate studies of
other GPCRs and integral membrane proteins.
MATERIALS AND METHODS
Materials
Vector pCEP4, Platinum Taq polymerase, T4 DNA ligase, and Lipofect-
amine 2000 were obtained from Invitrogen (Carlsbad, CA). Restriction
endonucleases were purchased from New England Biolabs (Beverly, MA).
Antibiotics and cell culture reagents were from Gibco (Invitrogen). Media
was sterile ﬁltered using a 0.2-mm ﬁlter kit (Millipore, Billerica, MA) and
tested periodically for contamination using a Mycoplasma Plus PCR primer
set (Stratagene, La Jolla, CA). Ten percent NuPAGE Bis-Tris poly-
acrylamide gels (Invitrogen) with MES running buffer were used for SDS-
PAGE and Western blotting according to manufacturer’s instructions.
Rabbit anti-hexahistidine and HRP-conjugated goat anti-rabbit antibodies
were obtained from Covance (Princeton, NJ). SuperSignal West Pico
chemiluminescent substrate (Pierce, Rockford, IL) and ECL Plus Western
blotting detection system (Amersham, Buckinghamshire, UK) were used for
antibody detection. [125I]N6-(4-amino-3-iodobenzyl)adenosine-59-N-meth-
yluronamide (125I-AB-MECA) was purchased from Perkin-Elmer Life
Sciences (Wellesley, MA). 2-Chloro-N6-(3-iodobenzyl)adenosine-59-N-
methyluronamide (Cl-IB-MECA), 59-(N-ethylcarboxamido)adenosine
(NECA), and (R)-N6-(1-methyl-2-phenylethyl)adenosine (R-PIA) were
from Sigma (St. Louis, MO). Optiﬂuor was from Wallac Oy. Ni-NTA
Superﬂow resin and Maxiprep DNA puriﬁcation kit were from Qiagen
(Valencia, CA). Protein concentration was determined using a membrane
protein compatible BCA assay (Pierce). Sodium dodecyl sulfate, Brij,
Tween 20, PEG 4000 distearate, and PEG 6000 distearate were obtained
from Sigma, whereas digitonin (high purity) was from Calbiochem (San
Diego, CA). All other surfactants used (Table 1) were purchased from
Anatrace (Maumee, OH).
Cloning, transfection, and expression
Full-length cDNA encoding the 957-bp human adenosine A3 receptor
(ADORA3) was a kind gift of Marlene Jacobson (Merck, Rahway, NJ). The
A3 fragment was ampliﬁed using standard polymerase chain reaction (PCR)
techniques. The forward primer 59 tttttttttggatccgctagcgccgccaccatggccaa-
caacagcactgctctgtca 39 introduced BamHI and NheI restriction endonuclease
sites (shown in italics) as well as an in-frame Kozak sequence (shown in
bold). The reverse primer 59 tttttttttctcgagtgataacaccatcaccatcaccatctactca-
gaattcttctcaatgct 39 introduced an XhoI restriction endonuclease site (shown
in italics) and a hexahistidine tag (shown in bold) to facilitate puriﬁcation
and detection of the receptor. The PCR product was digested using NheI and
TABLE 1 Summary of activity (Eq. 7), efﬁciency (Eq. 5), and
selectivity (Eq. 6) for entire surfactant set
Activity Efﬁciency Selectivity
1 Fos-Fenth 0.12 0.09 0.03
2 Nonopol-Fos 0.00 0.20 0.07
3 Fos-choline 0.16 0.14 0.04
4 Fos-choline 11 0.47 0.18 0.06
5 Fos-choline 13 0.48 0.18 0.05
6 Fos-choline 15 0.46 0.17 0.05
7 C8-b-D-thioglucoside 0.06 0.08 0.03
8 C7-b-D-glucoside 0.11 0.46 0.21
9 C8-b-D-glucoside 0.22 0.31 0.15
10 C9-b-D-glucoside 0.42 0.21 0.11
11 C10-b-D-glucoside 0.51 0.17 0.10
12 C8-b-D-thiomaltoside 0.63 0.56 0.25
13 C8-b-D-maltoside 0.31 0.18 0.10
14 C10-b-D-maltoside 0.61 0.33 0.20
15 C11-b-D-maltoside 0.81 0.36 0.24
16 C12-b-D-maltoside 0.70 0.46 0.35
17 HEGA8 0.24 0.12 0.05
18 HEGA9 0.42 0.40 0.18
19 HEGA10 0.60 0.48 0.22
20 HEGA11 0.66 0.55 0.27
21 CYMAL3 0.05 0.05 0.05
22 CYMAL4 0.08 0.07 0.07
23 CYMAL5 0.28 0.11 0.11
24 CYMAL6 0.46 0.16 0.16
25 C8E4 0.14 0.34 0.25
26 C8E5 0.50 0.36 0.23
27 C10E4 0.01 0.34 0.21
28 C10E5 0.21 0.09 0.06
29 C12E4 0.00 0.25 0.18
30 C12E5 0.16 0.05 0.03
31 C12E10 0.5 0.12 0.07
32 Brij 35 0.08 0.18 0.18
33 Brij 76 0.24 0.27 0.26
34 Brij 78 0.49 0.33 0.30
35 Brij 93 0.21 0.12 0.11
36 Brij 96 0.64 0.50 0.36
37 CHAPS 0.07 0.05 0.06
38 Big CHAPS 0.36 0.04 0.05
39 DDAO 0.08 0.16 0.08
40 Sodium cholate 0.46 0.12 0.00
41 Sarkosyl 0.16 0.24 0.06
42 Digitonin 0.82 0.78 0.40
43 C7-b-D-thioglucoside 0.04 0.40 0.21
45 C9-b-D-thioglucoside 0.00 0.29 0.17
46 C10-b-D-thioglucoside 0.00 0.25 0.13
48 C9-b-D-thiomaltoside 0.55 0.2 0.14
49 C10-b-D-thiomaltoside 0.52 0.59 0.29
50 C12-b-D-thiomaltoside 0.35 0.75 0.38
51 Surfonyl 485 0.06 0.02 0.02
52 Triton X-305 0.02 0.00 0.01
53 Triton X-405 0.10 0.00 0.00
54 Triton X-705 0.00 0.01 0.00
55 Tween 20 0.11 0.10 0.00
56 Brij 700 0.00 0.00 0.01
57 PEG 4000 distearate 0.00 0.00 0.02
58 PEG 6000 distearate 0.00 0.02 0.02
In all cases, the surfactant concentration was 20 mg/mL.
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XhoI and ligated into mammalian expression vector pCEP4 according to
the manufacturer’s instructions. Maxiprep puriﬁed DNA suitable for trans-
fection had a 280:260-nm absorbance ratio below 1 as determined by
ultraviolet spectrometry using a Beckman DU 7400 spectrophotometer.
HEK293E cells were seeded into six-well, 100-mm cell culture dishes
and grown to an approximate density of 106 cells per milliliter for trans-
fection, corresponding to .90% conﬂuency. After removal of media, the
cells were rinsed brieﬂy with pH 7, 50 mM potassium phosphate buffer and
Opti-MEM reduced serum was added to a ﬁnal volume of 1 mL. The ratio of
DNA/lipofectamine and total DNA-lipofectamine complex/media volume
were varied to identify optimal conditions for transfection; in general,
successful transfections favored high DNA to lipofectamine ratios and high
overall complex/media volume. Posttransfection (48 h), media was removed
and rinsed brieﬂy with PBS to remove residual lipofectamine, after which
1 mL of nonselective media was added. After 24 h incubation, conﬂuency
was;50%. At this point, cells were rinsed gently with nonselective media to
remove traces of lipofectamine and then incubated with selective media
containing 150 mg/mL hygromycin B for 8–11 days. During this time, media
were replaced every 3–4 days without passing cells, over which time con-
ﬂuency decreased to;10–20%. Individual colonies were then expanded and
expression levels veriﬁed by SDS-PAGE and Western blotting as described
below. Stable cell lines producing A3 remained viable for at least two
months, with an apparent doubling time roughly half that of control cells
transfected using pCEP4. For large-scale A3 expression, T-175 ﬂasks con-
taining 50 mL of media were seeded 1:10 and grown to .90% conﬂuency.
Cells were harvested by repeated rinsing and resuspending in 10 mL of lysis
buffer (pH 7, 50 mM potassium phosphate buffer containing 100 mM NaCl
and 50 mM EDTA). This suspension was centrifuged for 5 min at 4C,
40003 g, the supernatant decanted, and cell pellet stored at 80C.
Puriﬁcation and extraction
Frozen cell aliquots were thawed on ice and resuspended in 1–5 mL of lysis
buffer containing 100 mM PMSF; for SDS-PAGE, each cell pellet was from
100 mL of saturated media, whereas for immunoblotting and ligand binding,
each cell pellet was from 10 mL of saturated media. Throughout puriﬁcation,
each lane for SDS-PAGE was loaded with 20-mL samples using 10%
NuPAGE Bis-Tris polyacrylamide gels (Invitrogen) with MES sample
buffer and run at 80 V, 50 mA for 6 h at 4C. Gels were stained and
visualized using GelCode Plus staining reagent (Pierce). For immunoblot-
ting, samples were transferred using Invitrolon PVDF ﬁlter paper and blotted
using 1:1000 rabbit anti-A3 primary and 1:250 HRP-conjugated goat anti-
rabbit antibodies (Covance) as per manufacturer’s instructions. Visualiza-
tion was achieved using SuperSignal West Pico chemiluminescent substrate
(Pierce) and ECL Plus Western blotting detection system (Amersham).
Unless otherwise stated, all puriﬁcation and extraction steps were carried
out at 4C. To homogenize the pellet and lyse cells, this suspension was
sonicated on ice for 1 min at a 10% duty cycle with 10% output using
a Branson 450 sonicator and then pressed 40 times through a Dounce
homogenizer on ice. The lysate was centrifuged for 1 h at 90,0003 g to
collect membrane material, after which the pellet was resuspended in 1–5
mL of extraction buffer (pH 7, 25 mM potassium phosphate) and sonicated
on ice for 1 min at a 10% duty cycle with 10% output. Total mass of
membrane protein was determined using the micro BCA protein assay kit
(Pierce) with BSA as a standard. To minimize interference from lipids when
using the BCA method, the cell membrane pellet was resuspended in
1–5 mL of extraction buffer containing 2% (w/v) SDS (16). The solution
was incubated with gentle mixing for 2 h and then centrifuged at 90,0003 g
for 1 h. Generally, no pellet was observed after solubilization with SDS. The
amount of A3 present per mass of total membrane protein used in calculat-
ing efﬁciency (D in Eq. 5) was determined by competitive ligand bind-
ing experiments as discussed below.
Puriﬁcation of A3 was achieved using several different protocols. An
overview of each procedure used and its relationship to the activity,
efﬁciency, and selectivity measurements is given (Fig. 1). To determine
extraction efﬁciency, 1 mL aliquots of membrane suspension at a total
membrane protein concentration of 1 mg/mL were mixed with 0.1 mL of
a concentrated test surfactant solution such that the concentration of
surfactant was 20 mg/mL. Generally, this concentration of test surfactant
chosen fell within a range of 15–30 3 CMC for the entire set of surfactants
examined, with at least 500 test surfactant molecules present per membrane
protein molecule. This ensures adequate test surfactant is present to
solubilize the membrane. The membrane-surfactant mixture was incubated
with gentle mixing for 48 h and then centrifuged at 90,0003 g for 1 h.
The concentration of solubilized membrane protein used in calculating
selectivity (E in Eq. 6) was determined by the BCA method. For the BCA
measurement, the test surfactant concentration was reduced to 1% (w/v) in
all cases except for the alkyl polyglucosides, CHAPS, and digitonin, where
it was instead reduced to 0.1% (w/v), by diluting into SDS solution such
that the ﬁnal total surfactant concentration was 2% (w/v) as per the
manufacturer’s recommendations. The additional SDS was necessary to
maintain a minimum surfactant/protein ratio of 500 and prevent potential
membrane protein aggregation or precipitation, which would limit the
accuracy of the concentration measurement. As an additional correction, all
protein concentrations measured using the BCA method were blanked
against buffer containing the same total surfactant concentration and com-
position. The solubilized membrane protein solution (0.5 mL) was then
added to 50 mL of Ni-NTA resin containing 5% (v/v) glycerol and incubated
with gentle agitation for 6 h; glycerol was found to help prevent nonspeciﬁc
binding. The suspension was centrifuged for 10 min at 40003 g to collect
resin and resuspended in 0.5 mL of wash buffer (pH 6, 50 mMMES, 10 mM
imidazole) containing the same concentration of test surfactant. This wash
step was repeated twice to remove nonspeciﬁcally bound material. The test
surfactant was then exchanged for digitonin by washing twice with 0.5 mL
of a 3.5-mM stock solution in wash buffer. Competitive ligand binding was
then performed on the immobilized receptor as discussed below to determine
the amount of A3 extracted using a given test detergent to calculate both
efﬁciency (C in Eq. 5) and selectivity (C in Eq. 6).
For experiments to determine A3 activity in various detergents, a 3%
(w/v) digitonin solution was prepared by dissolving 30 mg of digitonin in
1 mL extraction buffer, heating for 10 min at 90C, cooling for 12–16 h at
4C, and centrifuging at 20,0003 g for 1 h to remove insoluble material. The
supernatant was stored at 4C until further use. The stock digitonin solution
(1 mL) was added to 5 mL of membrane suspension and mixed with gentle
agitation for 48 h. This solution was centrifuged for 1 h at 90,0003 g to
remove insoluble material, supernatant decanted, and added to 25 mL of
Ni-NTA resin. This sample was mixed with gentle agitation for 6 h and
resin collected by centrifugation for 10 min at 40003 g. The resin with
bound receptor was washed twice with pH 6, 50 mM MES buffer contain-
ing 10 mM imidazole and 3% (w/v) digitonin to remove nonspeciﬁcally
bound material. To determine the amount of bound receptor after washing
used in calculating activity (B in Eq. 7), competitive ligand binding was per-
formed as described below.
For detergent exchange, 100 mL of washed resin with bound receptor was
diluted into 1 mL of pH 6, 50 mMMES buffer containing a test detergent at
a concentration of 20 mg/mL, which ensures that at least 500 detergent
molecules are present per receptor. As was the case previously when mea-
suring efﬁciency (Eq. 5) and selectivity (Eq. 6), this choice of surfactant
concentrations ensures that adequate surfactant is present to solubilize the
receptor, thereby minimizing the possibility that loss of activity is due to lack
of surfactant. The resin was washed again with 1 mL of the new detergent
solution to remove residual digitonin, and mixed with gentle agitation for
24 h. The resin was then collected by centrifugation at 40003 g for 10 min.
The concentration of active A3 in the presence of a given test detergent used
to calculate activity (A in Eq. 7) was determined by competitive ligand
binding as described below. To ensure that activity measurements were not
biased by having the protein immobilized, control experiments were also
performed where the surfactant-solubilized receptor was eluted from the
particles using 0.2 M imidazole, diluted 10-fold into buffer at the same
surfactant concentration, allowed to equilibrate for 16 h in the absence of
particles, then incubated with Ni-NTA resin and competitive ligand binding
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performed as before (not shown). No signiﬁcant difference in activity was
measured between samples that were immobilized 2 h after extraction or
immobilized after equilibrating for 16 h, supporting the idea that ligand-
binding experiments performed on Ni-NTA particles accurately reﬂect
conditions in solution.
Competitive binding assay
For competitive binding experiments, 130 mL of detergent solution
containing immobilized A3 on Ni-NTA resin was combined with 10 mL of
a 13.5 nM 125I-AB-MECA stock solution (ﬁnal concentration 0.9 nM) and
10mL of stockNECA solutions spanning a range of ﬁnal concentrations from
10 to 1000 nM. The samples were incubated in Millipore MultiScreen 96-
well ﬁlter plates for 2 h at 20C, with gentle agitation. Nonspeciﬁc binding
was measured in each assay by subjecting mock-transfected cells to the same
conditions and procedures as the cells expressing A3. Binding reactions were
terminated by removing unbound ligands using a Millipore MultiScreen
vacuummanifold. The retentate was washed 3 times with 250 mL of ice-cold
extraction buffer containing an appropriate concentration of detergent.
Optiﬂuor (Wallac Oy) (250 mL) was then added to each well. Radioactivity
wasmeasured using a Perkin-Elmer 1450Microbeta scintillation counterwith
Microbeta workstation software version 3.01.005. In most cases, detergent
concentrations at an detergent/A3 ratio of 500:1 were most amenable to
ligand-binding experiments, whereas higher detergent concentrations led to
signiﬁcant nonspeciﬁc binding and often gave results that were not
interpretable, probably due to partitioning of the hydrophobic ligands into
detergent-rich domains formed on the resin surface. Therefore, a surfactant
concentration of 20 mg/mL was used in all cases. Each measurement was
performed in triplicate and the results averaged. Data were ﬁt to the following
competitive binding isotherm using Kaleidagraph 5.0 for Macintosh (17):
Y ¼ B1 T  B
11
X
IC50
 n: (1)
T refers to maximum speciﬁc activity, B is the minimum speciﬁc activity,
X is the competitor ligand concentration, and n is the Hill coefﬁcient. Kd
values for hot and cold ligands were obtained using the Cheng-Prushoff
equation (18).
Saturation binding assay
For saturation binding experiments, 150 mL of cell membrane suspension
was added to increasing concentrations of 125I-AB-MECA in a range of
0.1–20 nM. Solutions were incubated and treated, and the data collected
as described above for the competitive ligand-binding assay. Three sets of
independent measurements were taken over the entire range of concen-
trations. The results were averaged and ﬁt to a single-site, noncooperative
binding isotherm using Kaleidagraph 5.0 for Macintosh (17):
Y ¼ BmaxX
Kd1X
: (2)
Bmax refers to the maximum binding, X is the ligand concentration, and
Kd is the equilibrium ligand dissociation constant.
Surfactant characterization
HLB values for n-alkyl-b-D-glucosides (n ¼ 7–16) and n-alkyl-b-D-
thioglucosides (n ¼ 8–18) were determined from correlations based on
experimentally measured HLB values, the form of which is similar to Eq. 8
(19). The results of these correlations agree well with other experimentally
determined HLB values for n-octyl-b-D-glucoside as well as with the
proposed range of HLB values for alkyl polyglucosides (20). HLB values for
n-alkyl-b-D-maltosides were estimated from experimentally determined
values in a similar manner to the n-alkyl-b-D-glucosides (21). HLB values
for polyoxyethylene and additional surfactants were calculated from Eq. 8
using tabulated hydrophilic and lipophilic group numbers (22). In the case of
the PEG distearates and Sulfonyl 485, data provided by the manufacturers
were used in estimating HLB values according to Eq. 8. Surfactants 1–6, 17–
20, 21–24, and 37–41 (Table 1) were not included in the HLB calculations, as
adequate hydrophilic and lipophilic groupnumbers (Eq. 8)were not available.
To calculate packing parameters (Eq. 9), cross-sectional headgroup areas
for alkyl polyglucosides were taken from literature values (20,23,24). For
polyoxyethylene surfactants, average cross-sectional headgroup areas can be
calculated based on the number of ethoxylate (EO) units in the surfactant;
calculated areas for CiEj surfactants for j¼ 3–10 are in good agreement with
experimental values (25,26). In all cases, the literature values were compared
with experimentally determined values at the critical micelle concentration
(CMC) by the Wilhelmy plate method using a Kruss digital tensiometer
K10T (Hamburg, Germany). Speciﬁcally, the breakpoint in surface tension
versus log (surfactant concentration) was equated with the CMC and the
limiting cross-sectional headgroup area calculated from (27)
GMAX ¼ 4:3423 10
3
nRT
dg
d logC
 
T
(3)
AMIN ¼ 10
20
NGMAX
: (4)
G is the surface excess concentration (mol/m2), n is the number of species
of which the concentration at the interface varies with the surfactant bulk
phase concentration (n ¼ 1 for nonionic surfactants), R is the universal gas
constant, T is temperature (K), dg/dlogC is the maximum slope, N is
Avogadro’s number, and AMIN is the minimum headgroup area per surfac-
tant molecule (A˚2). Samples were prepared at a total volume of 30 mL and at
surfactant concentrations spanning two orders of magnitude above and
below the CMC. All measurements were made at 20C using a temperature-
controlled bath and allowed to equilibrate for 1 h after dilution.
Surfactants 1–6, 17–20, 21–24, and 33–42 (Table 1) were not included in
the packing parameter calculations (Eq. 9), as adequate cross-sectional
headgroup areas or deﬁnitions of chain lengths were not available. For
example, sodium cholate (40), CHAPS (37), and digitonin (42) have more
complicated structures; they do not have single hydrocarbon chain tails or
clearly deﬁned hydrophilic headgroups. Therefore, estimates of chain length
(Eq. 4) are not possible. Likewise, because the Brij surfactants (32–36, 56),
Sulfonyl 485 (51), Triton series (52–54), Tween 20 (55), and PEG dis-
tearates (57, 58) are in fact surfactant blends, individual values for the cross-
sectional headgroup areas could not be determined.
RESULTS
Characterization of A3 expression levels
in HEK293
To measure total expression levels and establish a baseline
for evaluation of different surfactants, we used radioligand
displacement isotherms to quantify the amount of A3
produced in HEK293 cells as well as the amount extracted
using digitonin. Digitonin is a natural surfactant that has
been shown previously to support activity of GPCRs, and
therefore was chosen for initial puriﬁcation before surfactant
screening (28). However, due to the heterogeneous nature of
digitonin as well as its large size relative to other single- or
double-chain surfactants, it may not be suitable for other
applications such as crystallization or spectroscopic studies.
We found that of the various competitor antagonists
commonly used for A3, NECA most efﬁciently displaced the
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radiolabeled I125-AB-MECA. Competitive ligand-binding
experiments using either digitonin-solubilized receptor
bound to Ni-NTA resin or whole-cell extracts gave similar
IC50 values (Fig. 2). From saturation binding studies the
concentration of functional receptor in the whole-cell extract
was determined to be 127.4 mg/L of culture, ;4.3 3 107
functional receptors per cell and 44 pmol functional receptor
per milligram membrane protein.
The details of the puriﬁcation of A3 are summarized in
Table 2, and a SDS-PAGE gel at each stage of puriﬁcation is
also given for comparison (Fig. 3 B). Immunoblotting using
A3-speciﬁc antibodies also indicates that the major band
observed after puriﬁcation corresponds to A3 (data not
shown). Competitive binding experiments with the digito-
nin-solubilized receptor gave concentrations within 10% of
those for the whole-cell extract, indicating that most of the
receptor expressed can be recovered using digitonin. These
concentrations are within an order of magnitude of those
observed previously for A1 in stably transfected HEK293
cells (29). Overall, these results conﬁrm that overexpression
in HEK293E cells and puriﬁcation using digitonin provides
a robust means by which to generate functional, puriﬁed re-
ceptor, and a benchmark against which we can compare the
effects of other surfactants.
FIGURE 1 Summary of experimen-
tal methods used to measure the various
parameters necessary to deﬁne activity
(Protocol 1, left column), selectivity,
and efﬁciency (Protocol 2, right col-
umn). The boldface letters refer to
variables used in the deﬁnitions for
activity (Eq. 7), efﬁciency (Eq. 5), and
selectivity (Eq. 6). These protocols are
described in detail in Materials and
Methods.
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Effect of surfactants on A3 extraction efﬁciency,
selectivity, and activity
To compare effects of different surfactant types on mem-
brane protein properties, 56 different surfactants common to
membrane protein studies were assayed for their ability to
extract A3 from the membrane and to maintain its ligand
binding activity once extracted. We used the following def-
initions to draw comparisons:
Efficiency ¼ Mass A3 extracted ðCÞ
Total mass A3 in membrane ðDÞ (5)
Selectivity ¼ Mass A3 extracted ðCÞ
Total mass membrane protein extracted ðEÞ:
(6)
Fig. 3 A shows a comparison of competitive binding
curves for selected surfactants after exchange from digitonin.
In general, IC50 values were essentially unchanged using the
different surfactants, whereas substantial differences were
seen in the maximal binding levels (Bmax) depending on the
surfactant used. Relative activity is deﬁned as:
Activity ¼ Maximal binding after surfactant exchange ðAÞ
Maximal binding in digitonin ðBÞ :
(7)
Thus, we deﬁne the activity of A3 in the different sur-
factants relative to the activity when solubilized in digitonin,
and we deﬁne efﬁciency and selectivity of the surfactants
based on the amount of A3 present in the HEK membranes.
The variables in Eqs. 5–7 refer to Fig. 1, which summarizes
the experimental procedures used to purify A3 receptor and
to measure activity (Protocol 1), efﬁciency (Protocol 2), and
selectivity (Protocol 2) in each surfactant. Table 1 lists the
surfactants used and their corresponding activities, efﬁcien-
cies, and selectivities; in all cases, the surfactant concentra-
tion used was 20 mg/mL, which ensured that at least 500
surfactant molecules were present per A3 receptor. The
number in the ﬁrst column is used to identify individual
surfactants on subsequent ﬁgures.
Fig. 4 compares differences in efﬁciency and selectivity
for selected surfactants, and emphasizes that surfactants with
different headgroups have very different effects on the re-
covery of A3. Even within a homologous series of surfac-
tants, increasing chain length also produces varying effects
depending on the surfactant family (Fig. 5). As an example,
for the glucoside family, increasing the carbon chain length
yields decreasing efﬁciency, whereas for the HEGA and
maltoside family, efﬁciency increases with carbon chain
length. This lack of a systematic trend illustrates the dif-
ﬁculty in identifying guidelines for selecting optimal sur-
factants for membrane protein puriﬁcation.
Interestingly, for the entire surfactant set, a strong cor-
relation exists between efﬁciency and selectivity; in other
words, increasing efﬁciency is accompanied by an increase
in selectivity (Fig. 6 A). Surfactants that are effective in
removing A3 from the membrane also enrich those extracts
in A3. Similarly, activity also correlates with selectivity, al-
though not as strongly (Fig. 6 B). This result implies that
surfactants that are effective in the puriﬁcation of A3 are also
likely to promote activity of A3.
Use of ligands to enhance puriﬁcation
It has been suggested that addition of ligands before ex-
traction can enhance the amount of receptor recovered, and
help to retain receptor activity (30). Speciﬁcally, puriﬁca-
tion of rat m3 muscarine receptor using CHAPS, digitonin,
or decyl-b-D-maltoside (DM) in conjunction with the
agonist N-[3H]methylscopolamine was found to increase
recoveries considerably, although this effect was surfactant
speciﬁc (31). We sought to test whether this strategy is
effective for A3. We added R-PIA, Cl-IB-MECA, and
NECA to the cell homogenate solution before extraction
FIGURE 2 Comparison of competitive ligand binding curves for A3 in
cell membranes (d) and in digitonin extracts (s). Measurements were made
at 20C using 100 mL of membrane or resin suspension in pH 7, 50 mM
potassium phosphate buffer containing 100 mM NaCl, and 50 mM EDTA.
The lines indicate the best ﬁts to a single-site, noncooperative binding
isotherm (Eq. 1). Points represent the average of at least three independent
measurements. Error in the measured radioactivity was ,5% of the value at
each data point.
TABLE 2 Summary of digitonin-solubilized A3 puriﬁcation
using Ni-NTA afﬁnity chromatography
Mass A3
(mg)
Mass
total
protein (mg) Selectivity*
Ki
NECA
(nM)
Ki
Cl-IB-MECA
(nM)
Initial 12.64 70120 – 120 3.3
Digitonin extract 5.32 80 0.06 174 3.1
Wash 3.56 4.57 0.78 150 3.1
Eluate 3.04 3.15 0.76 120 2.9
*Selectivity is deﬁned in Eq. 6.
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and compared the amount of A3 recovered for various
representative surfactants. The speciﬁcity of the ligand for
the receptor dictated its effectiveness in enhancing A3
recovery; Cl-IB-MECA was most effective (not shown).
Although, in general, adding Cl-IB-MECA did enhance
recovery for all surfactants, this was most pronounced for
surfactants that were otherwise poor in maintaining activity
or efﬁciency (such as CHAPS). When more effective
surfactants such as digitonin or DM were used, addition of
ligand provided little improvement. Overall, the effects of
ligand were fairly small, amounting to ,10% change in
recovery, whereas changing the surfactant type could alter
recovery by an order of magnitude or more.
Surfactant properties and A3 extraction
efﬁciency, selectivity, and activity
Although the correlations between selectivity, efﬁciency,
and activity are useful in guiding puriﬁcation, they give little
insight into why certain surfactants are effective for a given
membrane protein. As a result, membrane protein puriﬁca-
tion methods rely on extensive screening with many non-
ionic surfactants, as has been described for the neurokinin-1
and chemokine 5 receptors as well as for rhodopsin. To date,
there is no consensus on which aspects of the surfactants
used dictate their effectiveness in purifying receptors or
maintaining their activity (4,32,33). This uncertainty arises
in part because the large differences in the chemical structure
of various headgroups (alkyl polyglucosides or polyoxy-
ethylenes) or overall structure (CHAPS, sodium cholate, or
digitonin) make quantitative comparison difﬁcult. We sought
to address this problem by comparing various surfactant
properties with efﬁciency, selectivity, and activity of A3. Our
goal was to ﬁnd whether a general property exists that re-
ﬂects these functional properties of surfactants across various
families with different chemical structures.
One obvious candidate is the critical micelle concentra-
tion. CMC is a well-known surfactant property that reﬂects
the concentration at which the air-water interface of a given
solution has become saturated, so that additional monomers
associate in solution to form micelles (34). Comparison of
activity, efﬁciency, or selectivity with CMC indicates that no
general correlation or trend exists (Fig. 7); clearly CMC is
not a good predictor of whether a given surfactant will be
useful for puriﬁcation or handling of A3. Comparison with
surfactant aggregation number also did not yield any cor-
relation with activity, selectivity, or efﬁciency (not shown).
However, within individual surfactant families, increases
in efﬁciency, selectivity, or activity often do correlate with
increasing hydrocarbon tail length. This effect can be
understood in terms of an increasing hydrophobicity of the
surfactant, which may reﬂect its improved ability to partition
into the membrane and solubilize hydrophobic material.
Increasing chain length may also provide an improved
registry with the transmembrane region of the membrane
protein. Therefore, we hypothesized that a parameter that
reﬂects the relative solubility of both the hydrophobic and
hydrophilic portions of a surfactant would be more indicative
of its ability to purify and retain activity of a particular
membrane protein.
In this sense, the hydrophile-lipophile balance (HLB) is
a more useful quantitative, though empirical, parameter. The
HLB was originally developed as a scale to classify the
relative effectiveness of nonionic surfactants at forming
stable emulsions at room temperature (35). Surfactants with
FIGURE 3 (A) Competitive ligand binding results for selected surfactants
CYMAL6 (d), HEGA9 (s), Big CHAPS (:), and C10E5 (n). Measure-
ments were made at 20C using 100 mL of resin suspension in pH 7, 50 mM
potassium phosphate buffer containing 100 mM NaCl, and 50 mM EDTA.
The lines indicate the best ﬁts to a single-site, noncooperative binding
isotherm (Eq. 1). Points represent the average of at least three independent
measurements. Error was ,5% of the value at each data point. (B) SDS-
PAGE illustrating the puriﬁcation of A3 using Ni-NTA resin and surfactant
exchange. Lanes are as follows: MW, molecular weight ladder (in kDa); 1,
lysate from mock transfection; 2, lysate from stable transfection with A3;
3, insoluble fraction using 3% (w/v) digitonin; 4, soluble fraction using 3%
(w/v) digitonin; 5, supernatant after binding to Ni-NTA resin; 6 and 7, frac-
tions collected during elution with 0.2M imidazole fromNi-NTA resin in 3%
(w/v) digitonin; 8, puriﬁed A3 after exchange into unidecyl-b-D-maltoside;
9, puriﬁed A3 after exchange into HEGA 10. A summary of the amounts of
A3 recovered during each step in the puriﬁcation is given in Table 2.
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HLB values between 10 and 20 are water soluble and
generally form stable, oil-in-water emulsions, whereas sur-
factants with HLB values below 10 are oil soluble and
generally form water-in-oil emulsions (22).
In the original deﬁnition, HLB was meant to be a speciﬁc
property based solely on the chemical structure of a surfac-
tant. Each functional group was assigned a speciﬁc value
based on correlation of emulsion properties for various
surfactants. Thus, HLB was thought to be independent of
intensive variables such as temperature or ionic strength
(36,37). However, it has been shown that heating an oil-in-
water emulsion will lead to inversion, or formation of
a water-in-oil emulsion; the temperature at which this occurs
is the phase inversion temperature, and is common to many
nonionic surfactant emulsions (38). This inversion has been
interpreted as a consequence of the increase in relative
hydrophobicity of nonionic surfactants with temperature or
ionic strength, which in turn leads to a change in micelle
curvature and ultimately packing about the oil-water inter-
face (22). So, although HLB may include speciﬁc structural
information about a given surfactant, its interpretation in
terms of other physical properties is somewhat limited.
However, one advantage is that HLB numbers for single-
chain surfactants with relatively simple structures can be
measured experimentally or estimated based on correlations
(27):
HLB ¼ +H +L1 7: (8)
H represents group contributions for the hydrophilic
portions of the surfactant, and L the contribution from the
lipophilic portions. Experimentally determined HLB values
for several nonionic surfactants are available, as are
tabulated data for H and L for various hydrophilic and
lipophilic groups (27).
We evaluated the relationships between A3 activity,
efﬁciency, and selectivity and the HLB values for the
surfactants used in this study (Fig. 8). Strikingly, we ﬁnd that
an apparent maximum value for A3 activity occurs near an
HLB value of 15. Surfactants with HLB values higher or
lower than 15 supported lower levels of A3 activity. Note
that the surfactants used in identifying the HLB optima for
A3 represent a subset of the overall group of surfactants
examined (Table 1), because the necessary information used
to estimate HLB values (Eq. 8) was unavailable in several
cases, such as the CYMAL, HEGA, and Fos-choline
surfactants. Because activity correlates well with selectivity,
we observe a similar proﬁle for selectivity of A3 extraction;
optimal selectivity also occurs for surfactants with HLB
values around 15 (not shown). For efﬁciency of A3
extraction, the HLB proﬁle is similar but broader, with the
optimum efﬁciency between HLB values of 13 and 16 (not
shown). These exciting results suggest that HLB can be a
useful parameter in guiding selection of optimal surfactants
for integral membrane protein puriﬁcation.
FIGURE 4 Comparison of efﬁciency and selectivity for selected surfac-
tants. Efﬁciency is deﬁned in Eq. 5 and selectivity in Eq. 6.
FIGURE 5 Comparison of efﬁciency for selected surfactant groups
glucosides, maltosides, and HEGA as a function of chain length. Efﬁciency
is deﬁned in Eq. 5.
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DISCUSSION
HLB and surfactant structure
The observation that A3 activity and selectivity are optimized
in a window of HLB values offers promise for understanding
membrane protein-surfactant interactions, and for the de-
velopment of systematic approaches to surfactant selection.
Previous observations have also suggested that HLB may be
a useful parameter in membrane protein extraction (9,39–
44). The HLB optimum for A3 falls within a similar range
of 12–15 found for previous studies of membrane protein
puriﬁcation from prokaryotic and eukaryotic sources.
Speciﬁcally, D-alanine carboxypeptidase from Bacillus
subtilis was extracted at an HLB number of;12.8; maximal
activity also occurred near this value with Triton X-114,
Triton N-101, or Brij 56 (43). Similar values were also found
for the mitochondrial porin from bovine heart with Triton
X-114, octyl-b-D-glucoside (OG), or lauryl dimethylamine
oxide. It is noteworthy that such different membrane
compositions, protein types, and experimental methods all
lead to similar trends with HLB, especially when considering
that the current results include a much wider range of
surfactant types such as alkyl polyglucosides, glucamides,
FIGURE 6 (A) Correlation between efﬁciency and selectivity for all
surfactants. Numbers refer to individual surfactants listed in Table 1.
Efﬁciency is deﬁned in Eq. 5 and selectivity in Eq. 6. (B) Correlation
between activity and selectivity for all surfactants. Numbers identify the
surfactants (Table 1). Selectivity is deﬁned in Eq. 6 and activity in Eq. 7.
FIGURE 7 Comparison of CMC values and relative activity for all
surfactants. Numbers identify the surfactants (Table 1). Activity is deﬁned in
Eq. 7.
FIGURE 8 Comparison of HLB values and relative activity for all
surfactants. Numbers identify the surfactants (Table 1). Activity is deﬁned in
Eq. 7 and HLB in Eq. 8.
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and polyoxyethylene ethers. Furthermore, the apparent
correlation with activity and selectivity is also conserved,
suggesting that promoting solubility of a given membrane
protein may be a generally effective strategy in maintaining
their activity, because both of these are a direct result of the
properties of the surfactant used. Interestingly, the HLB
optimum for A3 is shifted relative to that of either mito-
chondrial porin or D-alanine carboxypeptidase; A3 favors
more hydrophilic nonionic surfactants such as DM, DDM, or
HEGA10 rather than Triton X-100 or OG. Understanding the
relationship between the HLB optimum and the properties of
the protein and its native membrane is the subject of our
current investigations.
We sought to interpret this apparent trend in terms of
micelle structure and its relationship to membrane protein
solubilization. For nonionic emulsions at room temperature,
the HLB scale reﬂects the relative packing at the oil-water
interface, which in turn dictates its ability to disperse oil
droplets in water effectively (35,45). Therefore, it is not
altogether unexpected that HLB should correlate with the
preference for a surfactant to assume a particular geometry at
a hydrophilic-lipophilic interface. Such suggestions have
been made based on estimates of effective chain or head-
group size, though for a limited range of surfactant types, and
in general are difﬁcult to extend to more complex structures
such as the alkyl polyglucosides (46).
One parameter that has been successfully used to cate-
gorize surfactant self-assembly and resultant phase structure
for various systems is the molecular packing parameter (47):
P ¼ v
al
; (9)
where v is the volume of the chain, l the length of the chain,
and a the cross-sectional area of the headgroup. Cross-
sectional headgroup areas were determined from CMC
measurements as discussed in Materials and Methods. For
single-chain hydrocarbon tails, one can estimate the length of
the chain as well as its volume from Israelachvili (48):
v ¼ 27:41 26:9n (10)
l ¼ 1:51 1:255n; (11)
where l is the length of the chain in A˚, v the volume of the
chain in A˚3, and n the number of hydrocarbon units in the
chain. Equations 10 and 11 are valid under the assumption
that the chain is at maximal extension for which it remains
ﬂuid; this is different from the maximal extension the chain
can assume, but is of similar magnitude. However, the
properties of the chain are not greatly inﬂuenced by the type
of headgroup for a given surfactant, and thus these
correlations hold reasonably well for a wide range of ionic,
zwitterionic, and nonionic surfactants (34). Packing param-
eter values can be used to estimate the aggregate shape based
on the geometry of the monomer, such as spherical (0–1/3),
cylindrical (1/3–1/2), and lamellar (1/2–1) (48).
Comparing results for the alkyl polyglucoside and poly-
oxyethylene surfactants, we ﬁnd that a linear correlation
exists between the HLB and packing parameter with a cor-
relation coefﬁcient .0.85 (Fig. 9). In other words, a de-
creasing HLB value leads to a more hydrophobic surfactant
and thus a preference for assuming a cylindrical or lamellar
structure. This effect is similar to the behavior of double-
chain surfactants such as lipids, where hydrophobic inter-
actions between the chains are dominant. Furthermore, the
different slopes for the alkyl polyglucosides and polyoxy-
ethylene families are not unexpected, because glucose is
much larger than an ethylene oxide headgroup, and would
therefore tend to inﬂuence the packing much more strongly.
This difference may explain the shallow slope for the alkyl
polyglucoside relative to the polyoxyethylene surfactants;
the dominant contribution of the glucose headgroup is
evident in the narrow range of packing parameters.
Comparing the activity of A3 with packing parameter, we
ﬁnd a similar optimum as we observed for HLB with a
maximum near packing parameter values of 0.39 (Fig. 10),
which corresponds to a cylindrical micelle for surfactants
such as unidecyl-b-D-maltoside or C12E10. Shorter chain
surfactants common for membrane protein studies, such as
OG or Triton X-100, have higher packing parameter values
near the limit of 1/2 for cylindrical micelles; these surfactants
lead to lower A3 activity. Likewise, the longer chain Brij
surfactants show lower activity but are relatively efﬁcient at
removing A3 from the membrane. These surfactants have
packing parameters near 0.33, which is the upper limit for
spherical micelles. Therefore, it might be the case that the
FIGURE 9 Correlation between HLB and packing parameter for alkyl
glucoside (s, n-alkyl-b-D-glucosides; d, n-alkyl-b-D-maltosides) and CiEj
(:, C12Ej; n, C10Ej; ¤, C8Ej) surfactants. Numbers refer to the number of
ethoxylate groups (j) for polyoxyethylene surfactants and chain length (n)
for alkyl glucosides. Lines represent best ﬁts to the data. Packing parameter
is deﬁned in Eq. 9.
Surfactant Effects on Adenosine Receptor 461
Biophysical Journal 89(1) 452–464
relative effectiveness of the long-chain maltosides (such as
unidecyl-b-D-maltoside) and polyoxyethylene surfactants
(such as C12E10, with larger proportions of ethylene oxide
subunits in their headgroup) arises from the fact that they can
form cylindrical micelles. This property could be favorable
for packing around the hydrophobic regions for less
spherical membrane proteins such as A3. Thus, the optimum
HLB values observed for various membrane proteins may in
effect be a consequence of such geometric constraints.
Puriﬁcation and surfactant properties
When designing a puriﬁcation strategy for a given membrane
protein, accounting for the effects of detergents on activity
and recovery is a major challenge. An important result of the
studies presented here is the strong positive correlation
between efﬁciency and selectivity (Fig. 6 A) and between
selectivity and activity (Fig. 6 B). Thus, detergents that are
optimal for isolation of the protein also maintain its activity
(and presumably its structure). This ﬁnding simpliﬁes the
choice of detergents.
The correlations observed involving efﬁciency and selec-
tivity may be related to lipid concentration and speciﬁcity
during surfactant solubilization. Lipids are known to play a
major role in membrane protein stability, function, and
structure determination, especially after solubilization with
a given surfactant (49–53). We are currently investigating
the effects of detergent/lipid ratio, and the extent to which it
inﬂuences properties such as efﬁciency and selectivity, as
well as membrane protein activity.
Use of ligands to enhance recovery
In certain cases, it may be necessary or advantageous to use
a particular surfactant even though it partially inactivates the
receptor. This loss of activity may be due to incompatibilities
with materials used in puriﬁcation or reagents used in
activity assays. We ﬁnd that some of the effects of various
surfactants can be offset by the use of a ligand speciﬁc to the
receptor of interest. For A3, the improvement in recovery
varied considerably across the different surfactant families
studied. Surfactants such as CHAPS or sodium cholate,
which tended to inactivate A3, showed the greatest improve-
ment with addition of NECA. However, the maximal re-
covery obtained in these cases was still considerably less
than that of more effective surfactants such as digitonin or
DDM. Furthermore, recoveries using digitonin and DDM
did not improve with added NECA. Therefore, it is likely
that for A3 the surfactant provides the primary inﬂuence on
recovery, whereas ligands play a lesser role in cases where
the surfactant is less effective.
Implications
Characterizing the recovery and activity of A3 in various
nonionic surfactants during puriﬁcation allowed us to
identify relationships among efﬁciency, selectivity, and
receptor activity. These relationships will allow one to
choose surfactants that are efﬁcient in removing A3 from the
membrane, with the likelihood that they will selectively
remove A3 relative to other membrane proteins and maintain
receptor activity. In cases where a less suitable surfactant
must be used, addition of speciﬁc agonists can also assist in
enhancing the recovery of A3. Likewise, surfactants such as
digitonin, which are unsuitable for crystallography or spec-
troscopy due to their heterogeneous nature, can be replaced
with other surfactants that maintain selectivity or activity
during puriﬁcation. Overall, these results allow for ﬂexibility
in choosing particular surfactants as well as a means to
enhance the purity of the initial extract, both of which are
important when working with receptors that express at low
levels.
Strikingly, the activity and solubility of A3 are optimized
over a fairly narrow window of surfactant HLB values.
Similar results have been observed previously for eukaryotic
and prokaryotic membrane proteins, although the range of
surfactant types tested in those studies was limited to mainly
polyoxyethylene surfactants. Nevertheless, the relationship
between HLB and membrane protein activity may be a
general feature of surfactant-solubilized membrane proteins.
If so, identiﬁcation of optimal surfactants could be simpliﬁed
to an initial screen of a set of surfactants that span a wide
range of HLB values, perhaps followed by a more focused
screen around a narrow HLB range.
The maximal HLB value of 15 for A3 is somewhat higher
than reported for other membrane proteins, which may
FIGURE 10 Comparison between activity and packing parameter for
alkyl polyglucoside and CiEj surfactants. Numbers identify the surfactants
(Table 2). Activity is deﬁned in Eq. 7 and packing parameter in Eq. 9.
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reﬂect differences in the relative hydrophobicity or structure
of A3. Although HLB is an empirical parameter, comparing
such values against the molecular packing parameter for
a given surfactant may suggest a reason that certain HLB
values are favored. Surfactants that support activity, such as
unidecyl-b-D-maltoside, have packing parameter values that
correspond to a cylindrical micellar shape, whereas other
surfactants that cause much higher levels of inactivation tend
to favor more spherical or lamellar geometries. Therefore,
the existence of an HLB optimum for A3 solubility and
activity probably reﬂects the ability of the surfactants to pack
effectively around the hydrophobic transmembrane region of
the protein. It will be interesting to determine whether these
ﬁndings can be generalized to other integral membrane
proteins, and which speciﬁc structural features of membrane
proteins inﬂuence the optimal HLB values. The ability to
predict which surfactants will be most useful for a given
membrane protein will be a valuable tool in the isolation and
characterization of these important and challenging proteins.
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